Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 71 | nsp7:L71I; | CL-3d; |
| 76 | nsp7:L76-; | CL-3c;CL-3e;CL-3f; |
| 76 | nsp7:L76V; | CL-3b;CL-3e; |
| 52 | nsp7:M52-; | CL-3e; |
| 52 | nsp7:M52I; | CL-3e; |
| 52 | nsp7:M52V; | CL-3d; |
| 62 | nsp7:M62L; | CL-3d;CL-3e;CL-5; |
| 62 | nsp7:M62V; | CL-3e; |
| 75 | nsp7:M75T; | CL-3b;CL-3e; |
| 69 | nsp7:N69-; | CL-3f; |
| 69 | nsp7:N69S; | CL-2;CL-3f; |
| 18 | nsp7:Q18L; | CL-3d; |
| 31 | nsp7:Q31-; | CL-3d; |
| 31 | nsp7:Q31H; | CL-3b; |
| 31 | nsp7:Q31L; | CL-3b; |
| 34 | nsp7:Q34H; | CL-3e;CL-5; |
| 34 | nsp7:Q34L; | CL-3e; |
| 63 | nsp7:Q63-; | CL-3b; |
| 21 | nsp7:R21G; | CL-3d; |
| 21 | nsp7:R21S; | CL-3e; |
| 79 | nsp7:R79-; | CL-3c; |
| 79 | nsp7:R79M; | CL-3e; |
| 10 | nsp7:S10L; | CL-3b; |
| 25 | nsp7:S25A; | CL-3e; |
| 26 | nsp7:S26-; | CL-3c;CL-3d;CL-3e;CL-3f; |
| 26 | nsp7:S26A; | CL-3d; |
| 4 | nsp7:S4A; | CL-3b; |
| 54 | nsp7:S54-; | CL-3b;CL-3e;CL-4; |
| 54 | nsp7:S54L; | CL-3e; |
| 57 | nsp7:S57-; | CL-3b;CL-3e; |
| 45 | nsp7:T45-; | CL-1a; |
| 45 | nsp7:T45P; | CL-3e; |
| 46 | nsp7:T46I; | CL-3d;CL-3e; |
| 46 | nsp7:T46N; | CL-3b; |
| 81 | nsp7:T81A; | CL-3c;CL-3e; |
| 9 | nsp7:T9I; | CL-3b;CL-3c;CL-3d;CL-3e; |
| 9 | nsp7:T9S; | CL-3e; |
| 11 | nsp7:V11I; | CL-3e; |
| 12 | nsp7:V12F; | CL-3e; |
| 16 | nsp7:V16A; | CL-3e; |
| 22 | nsp7:V22-; | CL-3c; |
| 22 | nsp7:V22I; | CL-3e; |
| 22 | nsp7:V22L; | CL-3d;CL-3e; |
| 33 | nsp7:V33-; | CL-3f; |
| 33 | nsp7:V33C; | CL-3d; |
| 33 | nsp7:V33I; | CL-3b;CL-3e; |
| 53 | nsp7:V53-; | CL-1b;CL-3e; |
| 58 | nsp7:V58G; | CL-1a_3b;CL-3b;CL-3e; |
| 58 | nsp7:V58I; | CL-3d;CL-3e;CL-3f; |
| 66 | nsp7:V66-; | CL-3f; |
Page 337 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com